Industries > Pharma > Cellular Immunotherapy Market Report 2021-2031

Cellular Immunotherapy Market Report 2021-2031

Forecasts by Therapy Type (CAR-T Cell Therapy, NK Cell Therapy, TIL Therapy, Others), by Products & Services (Cellular Immunotherapy Products, Cellular Immunotherapy Services), by Testing Assays Type (Bioanalytics, Characterization, Biosafety), by Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cellular Immunotherapy Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 08 June 2021
PAGES: 461
PRODUCT CODE: PHA1123
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA1123 Categories: , Tag:

Global Cellular Immunotherapy Market Outlook
According to Visiongain analysis, global cellular immunotherapy market was valued at US$xx billion in 2020 and is expected to grow at a CAGR of xx% during the forecast period 2021-2031 to reach US$xx billion by 2031.

Key Questions Answered by this Report:
• What is the current size of the overall global cellular immunotherapy market? How much will this market be worth from 2021 to 2031?
• What are the main drivers and restraints that will shape the overall cellular immunotherapy market over the next ten years?
• What are the main segments within the overall cellular immunotherapy market?
• How much will each of these segments be worth for the period 2021 to 2031?
• How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world cellular immunotherapy?
• What is their current status and how will they develop over the next ten years?
• What are their revenue potentials to 2031?
• How will political and regulatory forces influence regional markets?
• How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
• Who are the leading companies and what are their activities, results, developments and prospects?
• What are the leading cellular immunotherapy? What are their revenues and latest developments?
• What are some of the most prominent cellular immunotherapy currently in development?
• What are the main trends that will affect the world cellular immunotherapy market between 2021 and 2031?
• What are the main strengths, weaknesses, opportunities and threats for the market?
• What are the social, technological, economic and political influences that will shape that industry over the next ten years?
• How will the global cellular immunotherapy market evolve over the forecasted period, 2021 to 2031?
• What will be the main commercial drivers for the market from 2021 to 2031?
• How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?
• How will that industry evolve between 2021 and 2031, especially in R&D?

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

To access the data contained in this document please email contactus@visiongain.com

CTA

Rising demand for advanced therapies for cancer treatment is boosting the growth of global market. Find out why.
Immunotherapy, along with chemotherapy, surgery, and radiotherapy, has started to emerge as the “fourth pillar” of treatment for cancer in the last decade. Immunotherapy has transformed cancer treatment and revitalized tumor immunology. Several types of immunotherapy, including adoptive cell transfer (ACT) and immune checkpoint inhibitors (ICIs), have produced long-term clinical responses in cancer patients. The initial focus of CAR-T-cell therapies was primarily on ALL, the most common childhood cancer. The Food and Drug Administration (FDA) approved two CAR-T-cell therapies in 2017, one for the treatment of children with acute lymphoblastic leukemia (ALL) and the other for adults with advanced lymphomas.

Discover sales predictions for the global cellular immunotherapy market and submarkets
Over the last few years, cellular immunotherapy has gained widespread attention due to its high efficiency and adoption for the treatment of patients with severe cancer. Along with revenue prediction for the overall world market, there are 4 segmentations of the Cellular Immunotherapy market, with forecasts for 4 Therapy Type, 2 Products & Services, 3 Testing Assay Types, each forecasted at a global, regional, and country level, along with COVID-19 impact recovery pattern analysis for all segments.

Cellular Immunotherapy Market Report 2021-2031
Need industry data? Please contact us today.

Who are the leading players analysed in the market?
• Novartis AG
• Gilead Sciences, Inc.
• Adicet Bio
• GlaxoSmithKline plc.
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Iovance Biotherapeutics, Inc.
• Tessa Therapeutics Ltd.
• Inovio Pharmaceuticals, Inc.
• AstraZeneca
• Adaptimmune Therapeutics plc.
• Atara Biotherapeutics, Inc.
• Bristol-Myers Squibb Company
• APAC Biotech
• JW shinyak (JW CreaGene)

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Cellular Immunotherapy Market Report 2021-2031: Forecasts by Therapy Type (CAR-T Cell Therapy, NK Cell Therapy, TIL Therapy, Others), by Products & Services (Cellular Immunotherapy Products, Cellular Immunotherapy Services), by Testing Assays Type (Bioanalytics, Characterization, Biosafety), by Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cellular Immunotherapy Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Cellular Immunotherapy Market Report 2021-2031


Download sample pages

Complete the form below to download your free sample pages for Cellular Immunotherapy Market Report 2021-2031


Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

READ

Categories